Association Between anti-PD-1/PD-L1 Immune Checkpoint Inhibitors and Type 2 Airway Inflammation in Patients with Lung Cancer: the IMMUNEO Retrospective Case Series.
- DOI
- 10.1016/j.jaip.2026.09.008
- Published
- 2026 Sep 24
- Container
- The journal of allergy and clinical immunology. In practice
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.jaip.2026.09.008,
title = {Association Between anti-PD-1/PD-L1 Immune Checkpoint Inhibitors and Type 2 Airway Inflammation in Patients with Lung Cancer: the IMMUNEO Retrospective Case Series.},
author = {Lahmar Z and Wassmer F and Pissarra J and Duroyon MM and Côté A and Ahmed E and Bourdin A and Charriot J},
year = {2026},
journal = {The journal of allergy and clinical immunology. In practice},
doi = {10.1016/j.jaip.2026.09.008},
url = {https://doi.org/10.1016/j.jaip.2026.09.008}
}RIS
TY - JOUR TI - Association Between anti-PD-1/PD-L1 Immune Checkpoint Inhibitors and Type 2 Airway Inflammation in Patients with Lung Cancer: the IMMUNEO Retrospective Case Series. AU - Lahmar Z AU - Wassmer F AU - Pissarra J AU - Duroyon MM AU - Côté A AU - Ahmed E AU - Bourdin A AU - Charriot J PY - 2026 JO - The journal of allergy and clinical immunology. In practice DO - 10.1016/j.jaip.2026.09.008 UR - https://doi.org/10.1016/j.jaip.2026.09.008 ER -
APA
Z, L., F, W., J, P., MM, D., A, C., E, A., A, B., & J, C. (2026). Association Between anti-PD-1/PD-L1 Immune Checkpoint Inhibitors and Type 2 Airway Inflammation in Patients with Lung Cancer: the IMMUNEO Retrospective Case Series.. The journal of allergy and clinical immunology. In practice. https://doi.org/10.1016/j.jaip.2026.09.008
Source records
- pubmed · retrieved 2026-09-25T07:40:25.470Z